INSERM UMR 1037, Toulouse 31432, France.
Cancers (Basel). 2013 Dec 19;6(1):28-41. doi: 10.3390/cancers6010028.
KLF6 is ubiquitously expressed in human tissues and regulates many pathways such as differentiation, development, cellular proliferation, growth-related signal transduction, and apoptosis. We previously demonstrated that KLF6 expression is altered during liver carcinogenesis. More importantly, KLF6 invalidation results in cell cycle progression inhibition and apoptosis of liver cancer cells. On the other hand, enforced expression of KLF6 variant 2 (SV2) induces cancer cell death by apoptosis. Thus, we and others demonstrated that KLF6 and its splicing variants play a critical role in liver cancer. However, little is known on the mechanisms governing KLF6 expression in HCC. In the present work, we asked whether the 3' untranslated region (3'UTR) of the KLF6 mRNA may be responsible for regulation of KLF6 expression in HCC. We found that KLF6 mRNA stability was altered in liver-derived cell lines as compared to cervical cancer-derived cell lines and human embryonic fibroblasts. Interestingly, KLF6 mRNA was highly unstable in liver cancer-derived cell lines as compared to normal hepatocytes. We next cloned the KLF6 mRNA 3'UTR into luciferase-expressing vectors and found that gene expression and activity were strongly impaired in all liver-derived cell lines tested. In addition, we found that most the KLF6 3'UTR destabilisation activity resides between nt 1,835 and nt 2,615 of the KLF6 gene. Taken together, we provide the first steps towards better understanding of the regulation of KLF6 expression in HCC. Further work is needed to identify the factors that bind to KLF6 3'UTR to regulate its expression in liver cancer-derived cell lines.
KLF6 在人体组织中广泛表达,调节多种途径,如分化、发育、细胞增殖、生长相关信号转导和细胞凋亡。我们之前的研究表明,KLF6 的表达在肝癌发生过程中发生改变。更重要的是,KLF6 的无效导致肝癌细胞的细胞周期进展抑制和凋亡。另一方面,KLF6 变体 2(SV2)的强制表达通过细胞凋亡诱导癌细胞死亡。因此,我们和其他人证明 KLF6 及其剪接变体在肝癌中发挥关键作用。然而,对于控制 HCC 中 KLF6 表达的机制知之甚少。在本工作中,我们询问 KLF6 mRNA 的 3'非翻译区(3'UTR)是否可能负责调节 HCC 中的 KLF6 表达。我们发现与宫颈癌衍生细胞系和人胚胎成纤维细胞相比,肝源性细胞系中 KLF6 mRNA 的稳定性发生改变。有趣的是,与正常肝细胞相比,肝癌衍生细胞系中 KLF6 mRNA 的稳定性非常低。我们随后将 KLF6 mRNA 3'UTR 克隆到荧光素酶表达载体中,发现所有测试的肝源性细胞系中的基因表达和活性都受到强烈抑制。此外,我们发现 KLF6 3'UTR 大部分失稳活性位于 KLF6 基因的 nt 1,835 到 nt 2,615 之间。总之,我们朝着更好地理解 HCC 中 KLF6 表达调控迈出了第一步。需要进一步的工作来鉴定与 KLF6 3'UTR 结合以调节肝癌衍生细胞系中其表达的因子。